Probiotix Health (AQSE:PBX) EBITDA Margin % : -87.68% (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Probiotix Health's EBITDA for the six months ended in Jun. 2023 was £-0.48 Mil. Probiotix Health's Revenue for the six months ended in Jun. 2023 was £0.55 Mil. Therefore, Probiotix Health's EBITDA margin for the quarter that ended in Jun. 2023 was -87.68%.

Probiotix Health EBITDA Margin % Historical Data

The historical data trend for Probiotix Health's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health EBITDA Margin % Chart

Probiotix Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec22

EBITDA Margin %

-109.41

10.66

Probiotix Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
EBITDA Margin %	Get a 7-Day Free Trial			38.69	18.81	-94.70	-	-87.68

Competitive Comparison of Probiotix Health's EBITDA Margin %

For the Biotechnology subindustry, Probiotix Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Probiotix Health's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Probiotix Health's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Probiotix Health's EBITDA Margin % falls into.

Probiotix Health EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Probiotix Health's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	0	/	0
	=	%

Probiotix Health's EBITDA Margin % for the quarter that ended in Jun. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-0.484	/	0.552
	=	-87.68 %

Probiotix Health (AQSE:PBX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Probiotix Health EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Probiotix Health's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Probiotix Health (AQSE:PBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

X90:Germany

Address

Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB

Website

https://www.probiotixhealth-ir.com

Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines